Reply to "Keynote 48: Is it really for everyone?"

Affiliations

¹ Brigham and Women's Hospital, Boston, MA, United States; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States. Electronic address: jonathan_schoenfeld@dfci.harvard.edu.
² Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.
³ Brigham and Women's Hospital, Boston, MA, United States; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

Comment

Jonathan D Schoenfeld et al. Oral Oncol. 2021 Apr.

. 2021 Apr:115:105108.

doi: 10.1016/j.oraloncology.2020.105108. Epub 2020 Dec 1.

¹ Brigham and Women's Hospital, Boston, MA, United States; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States. Electronic address: jonathan_schoenfeld@dfci.harvard.edu.
² Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.
³ Brigham and Women's Hospital, Boston, MA, United States; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

No abstract available

Comment on

Keynote 48: Is it really for everyone?
Schoenfeld JD, Fell G, Haddad RI, Trippa L. Schoenfeld JD, et al. Oral Oncol. 2020 Jun;105:104762. doi: 10.1016/j.oraloncology.2020.104762. Epub 2020 May 4. Oral Oncol. 2020. PMID: 32381470 No abstract available.
Reply to "Keynote 48: Is it really for everyone?".
Burtness B, Ge J. Burtness B, et al. Oral Oncol. 2021 Jan;112:104983. doi: 10.1016/j.oraloncology.2020.104983. Epub 2020 Oct 6. Oral Oncol. 2021. PMID: 33032941 No abstract available.